Predictors of critical COVID-19 in an Iranian population: Age and disabilities play a special role

Bidari, Ali; Hassanzadeh, Morteza; Naderkhani, Mahya; Mesgarha, Milad Gholizadeh; Mohammad, Arash Pour; Azadeh, Alireza; Hossein, Hasti; Zarei, Elham; Khodadost, Mahmoud

doi:10.47176/mjiri.35.94

Cited by 12 publications

(14 citation statements)

References 16 publications

(21 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The authors of this study have worked on various clinical aspects of COVID‐19, COVID‐19 vaccination and dermatology 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 140 , 141 and it seems that this hot topic could answer some questions and concerns about the most encountered specific disorder in the field of dermatology.…”

Section: Discussionmentioning

confidence: 99%

A systematic review on mucocutaneous presentations after COVID‐19 vaccination and expert recommendations about vaccination of important immune‐mediated dermatologic disorders

Seirafianpour

Pourriyahi

Mesgarha

et al. 2022

Dermatologic Therapy

Self Cite

View full text Add to dashboard Cite

With dermatologic side effects being fairly prevalent following vaccination against COVID‐19, and the multitude of studies aiming to report and analyze these adverse events, the need for an extensive investigation on previous studies seemed urgent, in order to provide a thorough body of information about these post‐COVID‐19 immunization mucocutaneous reactions. To achieve this goal, a comprehensive electronic search was performed through the international databases including Medline (PubMed), Scopus, Cochrane, Web of science, and Google scholar on July 12, 2021, and all articles regarding mucocutaneous manifestations and considerations after COVID‐19 vaccine administration were retrieved using the following keywords: COVID‐19 vaccine, dermatology considerations and mucocutaneous manifestations. A total of 917 records were retrieved and a final number of 180 articles were included in data extraction. Mild, moderate, severe and potentially life‐threatening adverse events have been reported following immunization with COVID vaccines, through case reports, case series, observational studies, randomized clinical trials, and further recommendations and consensus position papers regarding vaccination. In this systematic review, we categorized these results in detail into five elaborate tables, making what we believe to be an extensively informative, unprecedented set of data on this topic. Based on our findings, in the viewpoint of the pros and cons of vaccination, mucocutaneous adverse events were mostly non‐significant, self‐limiting reactions, and for the more uncommon moderate to severe reactions, guidelines and consensus position papers could be of great importance to provide those at higher risks and those with specific worries of flare‐ups or inefficient immunization, with sufficient recommendations to safely schedule their vaccine doses, or avoid vaccination if they have the discussed contra‐indications.

show abstract

Section: Discussionmentioning

confidence: 99%

A systematic review on mucocutaneous presentations after COVID‐19 vaccination and expert recommendations about vaccination of important immune‐mediated dermatologic disorders

Seirafianpour

Pourriyahi

Mesgarha

et al. 2022

Dermatologic Therapy

Self Cite

View full text Add to dashboard Cite

show abstract

“…Dermatologists and physicians of all the other specialties should be familiarized with severe mucocutaneous manifestations in COVID‐19 patients since they might predict critical forms of the illness. 37 Particularly, vascular events and severe hypersensitivity drug eruptions must be identified promptly, and proper treatment is warranted which is further challenging in ICU admitted patients with multiple underlying conditions. 1…”

Section: Discussionmentioning

confidence: 99%

COVID‐19 and COVID‐19 vaccine‐related dermatological reactions: An interesting case series with a narrative review of the potential critical and non‐critical mucocutaneous adverse effects related to virus, therapy, and the vaccination

Mohammad

Mashayekhi

Seirafianpour

et al. 2022

Clinical Case Reports

Self Cite

View full text Add to dashboard Cite

This narrative review article was conducted to lay out a summarized but exhaustive review of current literature over mucocutaneous manifestations in 4 dimensions of SARS‐CoV‐2 pandemic: virus itself, treatment‐related, vaccine‐induced, and alteration of chronic dermatologic diseases following infection. Virus and vaccine‐related were mainly self‐limited and non‐severe. Treatment‐related reactions could be life‐threatening.

show abstract

“…Due to the limited capacity of ICUs and the high bed occupancy rate in countries with high rates of disease and most importantly, and in total ICU infrastructure, accurate identification of patients with the aim of minimizing the possibility of infection transmission between patients and from the patient to the treatment staff is very necessary and vital [22] (Figure 10). Another important issue in management of Covid-19 patients admitted to ICUs is the lack of specific recommendations on supportive ICU cares for such patients to minimize viral transmission [23]. One of the main concerns is high likelihood of aerosol generation by ICU supportive devices such as high-flow nasal cannula and non-invasive ventilation that are commonly used for ICUs patients [24].…”

Section: The Main Challenges Of Infection Controls In Icu S Referral ...mentioning

confidence: 99%

Untitled

Danesh

Barzegar

Maddahi³

et al. 2022

J. Med. Chem. Sci.

View full text Add to dashboard Cite

Unfortunately, many medical staff in hospitals and referral centers became ill, and some died due to frequent encounters with patients and severe cases of the disease. In the meantime, the issue of the spread of nosocomial infections should never be overlooked, and it should be thought that all attention should be focused on coronavirus, as the interaction between the virus and other strains of nosocomial infections is completely unknown. These measures are especially important in intensive care units for the care of Covid-19 patients, because the spread of this infection in these wards is strongly and exponentially associated with high mortality due to the disease. The outbreak of Covid-19 disease affected almost every country in the world, leading to more than 44 million cases and 1.2 million deaths by the end of October 2020. Another important point is the application of special and intensive protocols in the referral centers of patients in such a way as not only to prevent the spread of infection from disease to another patient but also to minimize the chances of infection of care and treatment personnel.

show abstract

Predictors of critical COVID-19 in an Iranian population: Age and disabilities play a special role

Abstract: Background severe disease available on CO COVID-19 in a Methods: In diagnosed betw a hospitalized p used univariab COVID-19, adm Results: Of t the multivariab ratio (OR), 2.3 with both COV 3.04; p=0.001) Conclusion: Also, the prese

Cited by 12 publications

References 16 publications

A systematic review on mucocutaneous presentations after COVID‐19 vaccination and expert recommendations about vaccination of important immune‐mediated dermatologic disorders

A systematic review on mucocutaneous presentations after COVID‐19 vaccination and expert recommendations about vaccination of important immune‐mediated dermatologic disorders

COVID‐19 and COVID‐19 vaccine‐related dermatological reactions: An interesting case series with a narrative review of the potential critical and non‐critical mucocutaneous adverse effects related to virus, therapy, and the vaccination

Untitled

Contact Info

Product

Resources

About